Variant Bio
Variant Bio develops therapies by studying the genes of people with exceptional health-related traits. It uses insights from human genetics to inform drug discovery and development, aiming to improve global health while prioritizing ethical partnerships and benefit-sharing with participating communities.
Facts
- HQ
- Seattle
- Sectors
- Biotechnology Research
- Founded
- 2018
- Employees
- 38
- Stage
- startup
- Members see funding amounts. .
- Founders
- Stephane Castel, PhD
Is this your organization? Claim it
Recent coverage
Front-page news, podcasts and videos about Variant Bio
Seattle Genomics Startup Variant Bio Secures Up to $50M Deal with Novo Nordisk to Study Metabolic Diseases Using Diverse Genomic Data
Seattle-based Variant Bio has partnered with Novo Nordisk in a multi-year deal worth up to $50 million to study metabolic diseases using genomic data from diverse populations. The collaboration aims to discover novel drug targets for diseases like obesity and diabetes by leveraging genetic data from globally diverse and underrepresented groups.
People
-
Stephane Castel Founder, Chief Technology Officer & Chief Scientific Officer
-
Andrew Farnum Executive, Chief Executive Officer
-
Craig Basson Executive, Chief Medical Officer, President of R&D
Online
Questions about Variant Bio
What is Variant Bio?
Variant Bio is a startup based in Seattle that develops therapies by studying the genes of people with exceptional health-related traits, using human genetics to inform drug discovery and development.
What is Variant Bio known for?
Variant Bio emphasizes ethical partnerships and benefit-sharing with communities participating in its genetics research.
What has Variant Bio been in the news for?
GeekWire reported in January 2025 that Variant Bio secured a deal with Novo Nordisk to study metabolic diseases using diverse genomic data.
Who are the people behind Variant Bio?
Stephane Castel is Variant Bio’s founder, chief technology officer and chief scientific officer. Andrew Farnum is chief executive officer, and Craig Basson is chief medical officer and president of R&D.
Who invested in Variant Bio, and how much has it raised?
Members of Seattle Flow see Variant Bio's funding rounds, amounts and investors on its Funding tab. Joining is free.
Where is Variant Bio based?
Variant Bio is based in Seattle.